Table 1.
Reduction of “seronegativity” frequency by use of recombinant antigen–based assays to retest all available serum specimens from 49 patients with NMO consistently scored negative by tissue-based indirect immunofluorescence assay
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.